The Northeast ALS Consortium is pleased to announce the results of the election for the Co-Chair, Investigator, and Evaluator positions on the NEALS Executive Committee.
Trial News & Events
The 12th Annual Meeting of NEALS was the largest and most information-packed meeting yet. Over 300 clinicians, nurses, therapists, and researchers came together to take stock of the many efforts being coordinated by NEALS, and to accelerate the pace of clinical research in ALS.
“Leading NEALS is one of the things in my professional career I am proudest of,” says Shefner.
The University City Science Center in Philadelphia has awarded Temple two proof-of-concept grants: one for the development of a novel therapy for the treatment of amyotrophic lateral sclerosis (ALS) and another for the creation of a software program that will hone physicians’ ability to read and diagnose electroencephalography, or EEGs.
Neuralstem, Inc. has announced that the first patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of ALS at Emory University Hospital in Atlanta, Georgia.
Cytokinetics Announces Publication of Results from Phase II Trials of Tirasemtiv in Patients with AL
Cytokinetics announced the publication of two manuscripts reporting data from two prior clinical trials of tirasemtiv, highlighting encouraging results.
NEALS Executive Committee Member Terry Heiman-Patterson, MD (Drexel University and the ALS Hope Foundation) leads this effort with the goal of providing advocacy training to PALS in and around the surrounding areas.
Dr. Jeff Rothstein provides medical and research insights during CNN's Three-Part Series on ALS with news anchor Suzanne Malveaux.
On behalf of the Executive and Abstract Committees for the 12th Annual NEALS Meeting, we would like to extend an invitation for members to submit an abstract for consideration for presentation at the Annual Meeting.
The event will take place at the Sandpearl Resort in Clearwater Beach, Florida, on Friday October 4th to Saturday October 5th. The deadline for nominations is August 2nd, 2013.